Arestat™ Protein Stabilization Technology
Arestat™ comprises two fundamentally different aspects of our platform stabilization technology. Both utilize excipients and buffers approved by the FDA and EMEA in an unconventional manner to achieve the desired stability.
arestat-t
stabilizes biologics in storage at elevated temperatures and higher concentrations
arestat-r
stabilizes biologics exposed to industrial standard dose of sterilizing radiation
Both platform technologies are available for licensing for applications involving therapeutic proteins, vaccines, medical devices and diagnostics.
Case Studies
Arestat™ technologies have been applied to biopharmaceuticals, medical devices and diagnostics yielding successful outcomes to both in-house development programs and partnered collaborations.
The effectiveness of Arestat™ technologies in various scenarios is illustrated in the case studies:
©Arecor 2010. All rights reserved. Designed & developed by The Refinery